Ticker Details
MaxCyte, Inc. Common Stock
IPO Date:	July 26, 2021
Sector:	Healthcare
Industry:	Medical Devices
Market Cap:	$81.21M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.15 | 3.03%
Avg Daily Range (30 D):	$0.02 | 3.07%
Avg Daily Range (90 D):	$0.03 | 3.05%

Institutional Daily Volume
Avg Daily Volume:	.57M
Avg Daily Volume (30 D):	.86M
Avg Daily Volume (90 D):	.96M

Trade Size
Avg Trade Size (Sh.):	117
Avg Trade Size (Sh.) (30 D):	165
Avg Trade Size (Sh.) (90 D):	198

Institutional Trades
Total Institutional Trades:	169
Avg Institutional Trade:	$2.35M
Avg Institutional Trade (30 D):	$1.67M
Avg Institutional Trade (90 D):	$2.64M
Avg Institutional Trade Volume:	.4M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$4.11M
Avg Closing Trade (30 D):	$1.67M
Avg Closing Trade (90 D):	$1.67M
Avg Closing Volume:	530.47K

News

Jan 12, 2026 @ 1:05 PM MaxCyte Announces Preliminary Unaudited Fourth Qua... Source: Globe Newswire

Jul 4, 2024 @ 1:11 PM Global Transfection Technologies Market Predicted ... Source: Polaris Market Research (Pmr)

Jun 13, 2024 @ 1:55 PM Does MaxCyte (MXCT) Have the Potential to Rally 85... Source: Zacks Equity Research

Jun 13, 2024 @ 12:50 PM Recent Price Trend in MaxCyte (MXCT) is Your Frien... Source: Zacks Equity Research

May 29, 2024 @ 12:05 PM MaxCyte to Participate in William Blair 44th Annua... Source: MaxCyte, Inc

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$-.42	$-.09	$-.42
Diluted EPS	$-.42	$-.09	$-.42
Revenue	$33.03M	$7.3M	$33.03M
Gross Profit	$26.8M	$5.69M	$26.8M
Net Income / Loss	$-44.63M	$-9.6M	$-44.63M
Operating Income / Loss	$-51.9M	$-11.23M	$-51.9M
Cost of Revenue	$6.22M	$1.61M	$6.22M
Net Cash Flow	$-7.82M	$7.09M	$-7.82M
PE Ratio